ogi
Organigram Approved To Trade On NASDAQ Global Select Market
After applying to the NASDAQ Global Select Market last month, Organigram Holdings Inc. (TSX-V: OGI; OTCQX: OGRMF) has now received…
Aurora Cannabis Q3 2019 Earnings Review – Holding Pattern Continues
Aurora (TSX: ACB) reported Q3 earnings and showed growth in revenue, gross profit while decreasing costs. However, concerns remain with…
Cannabis Council Of Canada Recruits Board Members From Organigram, Aphria
More than half a year into legalized recreational cannabis usage in Canada, 11 movers and shakers from the licensed market…
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (April 27th, 2019)
The 17 Edible Products Coming to Canada Later This Year Bottom Line: The release of edibles should help reenergize…
Aphria Q3 2019 Earnings Review – Headlines Create Opportunity
Aphria (TSE: APHA) posted messy quarterly results but remains an undervalued name with big revenue potential later in 2019.
Organigram 2Q 2019 Earnings Review – Selling Cannabis Customers Want
Organigram (CVE: OGI) posted another strong quarter. As a smaller producer, their cannabis production capabilities are impressive and undervalued.
Canadian Cannabis Scorecard (Spring 2019)
Confused about which marijuana stocks are worth your money? The Canadian Cannabis Scorecard is your guide to separating the best…
Organigram Announces Board Member Resignation, Launches Patient App
Organigram Holdings Inc. (TSX-V: OGI; OTCQX: OGRMF) today announced the resignation of the company’s chief medical member from the board…
HEXO Q2 2019 Earnings – On the Edge of Profitability
A full review of HEXO (TSE: HEXO) Q2 2019 earnings. Should you buy this value priced name or are there…